Global Cell Therapy Biomanufacturing Market 2022-2028

Region:Global

Author(s):

Product Code:GB02326R

Download Sample Report download
Buy the Full ReportStarting from $2600
Published on

June 2022

Total pages

80

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2600

About the Report

About the Report

Cell therapies aims to introduce new, healthy cells into a patient's body, to replace the diseased or missing ones. Manufacturing them involves collecting a specific set of cells from the blood, modifying them to produce a more vigorous attack on a patient's cancer cells, and then reinjecting them into the patient. The global cell therapy biomanufacturing market is likely to register a CAGR of over 8.8% with an incremental growth of USD 4 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cell therapy biomanufacturing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cell therapy biomanufacturing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for cell therapy biomanufacturing can be segmented by application: bone repair, cancer, cardiovascular diseases, neurological disorders, skeletal muscle repair, others. In 2021, the skeletal muscle repair segment made up the largest share of revenue generated by the cell therapy biomanufacturing market. Cell therapy biomanufacturing market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global cell therapy biomanufacturing market in 2021.

By application:

- bone repair

- cancer

- cardiovascular diseases

- neurological disorders

- skeletal muscle repair

- others

By region:

- Asia Pacific

- Europe

- North America

- MEA (Middle East and Africa)

- Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Bone Therapeutics S.A., Caladrius Biosciences, Inc., Iovance Biotherapeutics, Inc., Lonza Group AG, Merck KGaA, Novartis AG, Regen BioPharma, Inc., Regeneus Ltd., The Bristol-Myers Squibb Company (BMS), among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

- To analyze and forecast the market size of the global cell therapy biomanufacturing market.

- To classify and forecast the global cell therapy biomanufacturing market based on application, region.

- To identify drivers and challenges for the global cell therapy biomanufacturing market.

- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cell therapy biomanufacturing market.

- To identify and analyze the profile of leading players operating in the global cell therapy biomanufacturing market.

Why Choose This Report

- Gain a reliable outlook of the global cell therapy biomanufacturing market forecasts from 2022 to 2028 across scenarios.

- Identify growth segments for investment.

- Stay ahead of competitors through company profiles and market data.

- The market estimate for ease of analysis across scenarios in Excel format.

- Strategy consulting and research support for three months.

- Print authentication provided for the single-user license.

Products

Products

Cell Therapy Biomanufacturing,


Companies

Bone Therapeutics S.A., Caladrius Biosciences Inc., Iovance Biotherapeutics Inc., Lonza Group AG, Merck KGaA, Novartis AG, Regen BioPharma Inc., Regeneus Ltd., The Bristol-Myers Squibb Company (BMS)

Table of Contents

Table of Contents

TABLE OF CONTENTS

FIGURES AND TABLES

PART 1. INTRODUCTION

- Report description

- Objectives of the study

- Market segment

- Years considered for the report

- Currency

- Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

- Introduction

- Drivers

- Restraints

- Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY APPLICATION

- Bone repair

- Cancer

- Cardiovascular diseases

- Neurological disorders

- Skeletal muscle repair

- Others

PART 6. MARKET BREAKDOWN BY REGION

- Asia Pacific

- Europe

- North America

- MEA (Middle East and Africa)

- Latin America

PART 7. KEY COMPANIES

- Bone Therapeutics S.A.

- Caladrius Biosciences, Inc.

- Iovance Biotherapeutics, Inc.

- Lonza Group AG

- Merck KGaA

- Novartis AG

- Regen BioPharma, Inc.

- Regeneus Ltd.

- The Bristol-Myers Squibb Company (BMS)

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022